Caveolin-1 is a negative regulator of MMP-1 gene expression in human dermal fibroblasts via inhibition of Erk1/2/Ets1 signaling pathway

Journal of Dermatological Science

Volumn 64, Issue 3, 2011, Pages 210-216

  Haines, Paul ^a   Samuel, Glady H ^a   Cohen, Heather ^a   Trojanowska, Maria ^a   Bujor, Andreea M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caveolin 1; Extracellular matrix; MMP 1

Indexed keywords

CAVEOLIN 1; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SPHINGOMYELIN PHOSPHODIESTERASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; WESTERN BLOTTING;

BLOTTING, WESTERN; CAVEOLIN 1; CELLS, CULTURED; DERMIS; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEIN C-ETS-1; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSFECTION;

EID: 80055066984     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.08.005     Document Type: Article

References (37)

1. Lajoie P., Nabi I.R. Lipid rafts, caveolae, and their endocytosis. Int Rev Cell Mol Biol 2010, 282:135-163.
2. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293(5539):2449-2452.
3. Fra A.M., Williamson E., Simons K., Parton R.G. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 1995, 92(19):8655-8659.
4. Cremesti A.E., Goni F.M., Kolesnick R. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?. FEBS Lett 2002, 531(1):47-53.
5. Liu P., Anderson R.G. Compartmentalized production of ceramide at the cell surface. J Biol Chem 1995, 270(45):27179-27185.
6. Gulbins E., Kolesnick R. Raft ceramide in molecular medicine. Oncogene 2003, 22(45):7070-7077.
7. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
8. Vincenti M.P., Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002, 4(3):157-164.
9. Nakerakanti S.S., Kapanadze B., Yamasaki M., Markiewicz M., Trojanowska M. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 2006, 281(35):25259-25269.
10. Felicetti F., Parolini I., Bottero L., Fecchi K., Errico M.C., Raggi C., et al. Caveolin-1 tumor-promoting role in human melanoma. Int J Cancer 2009, 125(7):1514-1522.
11. Tourkina E., Richard M., Oates J., Hofbauer A., Bonner M., Gooz P., et al. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis 2010, 69(6):1220-1226.
12. Chow A.K., Daniel E.E., Schulz R. Cardiac function is not significantly diminished in hearts isolated from young caveolin-1 knockout mice. Am J Physiol Heart Circ Physiol 2010, 299(4):H1183-H1189.
13. Labrecque L., Nyalendo C., Langlois S., Durocher Y., Roghi C., Murphy G., et al. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem 2004, 279(50):52132-52140.
14. Bujor A.M., Nakerakanti S., Morris E., Hant F.N., Trojanowska M. Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts. Exp Dermatol 2010, 19(4):347-354.
15. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998, 95(5):2509-2514.
16. Kim S., Han J., Lee D.H., Cho K.H., Kim K.H., Chung J.H. Cholesterol, a major component of caveolae, down-regulates matrix metalloproteinase-1 expression through ERK/JNK pathway in cultured human dermal fibroblasts. Ann Dermatol 2010, 22(4):379-388.
17. Engelman J.A., Chu C., Lin A., Jo H., Ikezu T., Okamoto T., et al. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 1998, 428(3):205-211.
18. Cohen A.W., Park D.S., Woodman S.E., Williams T.M., Chandra M., Shirani J., et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 2003, 284(2):C457-C474.
19. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003, 2:29.
20. Bu S., Yamanaka M., Pei H., Bielawska A., Bielawski J., Hannun Y.A., et al. Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. FASEB J 2006, 20(1):184-186.
21. Jinnin M., Ihn H., Mimura Y., Asano Y., Yamane K., Tamaki K. Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res 2005, 33(11):3540-3549.
22. Tourkina E., Richard M., Gooz P., Bonner M., Pannu J., Harley R., et al. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2008, 294(5):L843-L861.
23. Wang X.M., Kim H.P., Song R., Choi A.M. Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. Am J Respir Cell Mol Biol 2006, 34(4):434-442.
24. Wang X.M., Zhang Y., Kim H.P., Zhou Z., Feghali-Bostwick C.A., Liu F., et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 2006, 203(13):2895-2906.
25. Li H., Nord E.P. Functional caveolae are a prerequisite for CD40 signaling in human renal proximal tubule cells. Am J Physiol Renal Physiol 2004, 286(4):F711-F719.
26. Pike L.J. Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim Biophys Acta 2005, 1746(3):260-273.
27. Williams T.M., Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005, 288(3):C494-C506.
28. Patel H.H., Murray F., Insel P.A. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 2008, 48:359-391.
29. Del Galdo F., Sotgia F., de Almeida C.J., Jasmin J.F., Musick M., Lisanti M.P., et al. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum 2008, 58(9):2854-2865.
30. Yokomori H., Oda M., Yoshimura K., Nomura M., Wakabayashi G., Kitajima M., et al. Elevated expression of caveolin-1 at protein and mRNA level in human cirrhotic liver: relation with nitric oxide. J Gastroenterol 2003, 38(9):854-860.
31. Razani B., Zhang X.L., Bitzer M., von Gersdorff G., Bottinger E.P., Lisanti M.P. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem 2001, 276(9):6727-6738.
32. Kim S., Lee Y., Seo J.E., Cho K.H., Chung J.H. Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts. Cell Signal 2008, 20(7):1313-1319.
33. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001, 276(41):38121-38138.
34. Witkiewicz A.K., Dasgupta A., Sotgia F., Mercier I., Pestell R.G., Sabel M., et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 2009, 174(6):2023-2034.
35. Boire A., Covic L., Agarwal A., Jacques S., Sherifi S., Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005, 120(3):303-313.
36. Tang W., Hemler M.E. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering. J Biol Chem 2004, 279(12):11112-11118.
37. Galvez B.G., Matias-Roman S., Yanez-Mo M., Vicente-Manzanares M., Sanchez-Madrid F., Arroyo A.G. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell 2004, 15(2):678-687.